搜索 | FaceYa

添加了博客其他

2026-05-28 08:09:27 -

New Application Scenarios for the AS01 Adjuvant: The ACI-24.060 Alzheimer’s Disease Vaccine Project

The treatment of Alzheimer’s Disease (AD) has entered the era of "Disease-Modifying Therapies" (DMTs). With the approval of anti-Aβ monoclonal antibodies (such as Lecanemab), the Amyloid Cascade Hypothesis has received clinical validation. However, the safety risks associated with ARIA (Amyloid-Related Imaging Abnormalities) in monoclonal antibody therapies, as well as their high...

0 评论 0 分享 130 浏览次数 0 评价